Breath Test Feasibility Trial for COVID-19 Infection Diagnosis
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Covid19
- Sponsor
- Medical University of South Carolina
- Enrollment
- 100
- Locations
- 1
- Primary Endpoint
- Provide an adequate sample and compare the signals given from the two groups.
- Status
- Completed
- Last Updated
- 3 years ago
Overview
Brief Summary
This study is designed to look at the effectiveness of a new technology call Nanotechnology Biomarker Tagging (NBT) in detecting COVID-19 infection using breath samples of patients. Participation in this study is expected to take less than one month and will consist of a breath sample being taken by the research team, a cheek swab being taken by the research team, a questionnaire that will be completed by the participant with the help of the research teams, and a review of your medical record.
Investigators
Gerard Silvestri, MD
Professor of Medicine
Medical University of South Carolina
Eligibility Criteria
Inclusion Criteria
- •Age 18 years and older
- •Patients that present for COVID-19 testing, have tested Covid negative, or Covid Positive patients.
Exclusion Criteria
- •Unable to consent
- •Patients on a ventilator
- •Pregnant Women
Outcomes
Primary Outcomes
Provide an adequate sample and compare the signals given from the two groups.
Time Frame: 10 minutes
The samples from the participants will be analyzed to identify the different signals given from Covid-19 positive patients and Covid-19 negative patients